Trump Blueprint

Trump’s Blueprint on International Drug Pricing; What to Expect

The U.S. always stood out as a different healthcare system. Well, maybe not anymore. The Trump Administration released an International Drug Pricing blueprint in 2018 and it was received with…

Read Full Article

Discount Safe Harbor Proposed Rule: How Process Works and What does it mean?

July 2019 Update As first reported by The Wall Street Journal and Axios on July 11, 2019, the Trump Administration has decided to abandon implementation of the proposed Discount Safe…

Read Full Article

Switch Operator – Current Role and Potential Impacts

Co-written by Catherine Trentini, Senior Consultant, Pricing, Contracting & Market Access As the healthcare industry is in a state of rapid change, the pharmaceutical supply chain and how consumers receive…

Read Full Article

Can Congress Delay the Safe Harbor Proposed Rule?

July 2019 Update As first reported by The Wall Street Journal and Axios on July 11, 2019, the Trump Administration has decided to abandon implementation of the proposed Discount Safe…

Read Full Article

Medicare Part D Bids and Discount Safe Harbor Timeline

For those whose only association with Medicare comes from being a participant in a health insurance plan, chances are individuals are not aware of the extensive path each plan takes…

Read Full Article

Trump’s blueprint and manufacturer impacts

Due to the unabated growth of prescription drug prices and the resulting increase in consumer spending, drug prices have become a highly prioritized public health matter. To address this issue,…

Read Full Article